Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cros

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Translational Oncology|December 15, 2021
Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancerR Nicolle, O Gayet, M Bigonnet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2024
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinomaN Fraunhoffer, P Hammel, T Conroy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2020
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinomaR Nicolle, O Gayet, P Duconseil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instabilityT Ratovomanana, R Nicolle, R Cohen, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Translational Oncology|December 15, 2021
Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancerR Nicolle, O Gayet, M Bigonnet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2024
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinomaN Fraunhoffer, P Hammel, T Conroy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2020
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinomaR Nicolle, O Gayet, P Duconseil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instabilityT Ratovomanana, R Nicolle, R Cohen, et al.
Pageof 10